LEGN Legend Biotech Corporation
LEGN Legend Biotech Corporation
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-16 1 bear converging
POC $18.45 · VWAP $23.48 · -21.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CFO, Director sold $308.6K, Sep 23–Oct 1
Coverage
2 watchlists
LEGN Price Structure
Loading timeframes…
Peers
Every watchlist LEGN belongs to, members best 30-day change first — LEGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
Legend Biotech furnished its report for the period ended June 30, 2026 to the SEC on Form 6-K on August 11, 2026. No figures from this filing are recorded here.
full note →Against street estimates
How LEGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
LEGN research tape
69 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.